Stephen Bagley
Impact in
Papers in
- Co-authors
- Donald M. O’Rourke (40 shared papers)Arati Desai (40 shared papers)Corey J. Langer (14 shared papers)Gerald P. Linette (3 shared papers)Carl H. June (2 shared papers)Joshua Bauml (10 shared papers)Steven Brem (32 shared papers)Charu Aggarwal (9 shared papers)
- Journals
- Neuro-Oncology (21 papers)Journal of Clinical Oncology (14 papers)Neuro-Oncology Advances (6 papers)Journal of Thoracic Oncology (5 papers)Journal of Neuro-Oncology (4 papers)
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
Stephen Bagley
97 papers receiving 2.1k citations
Stephen Bagley's Hit Papers
Peers
Comparison fields: 5 of 100
- Genetics 581
- Oncology 891
- Cancer Research 267
- Immunology 349
- Radiology, Nuclear Medicine and Imaging 234
Countries citing papers authored by Stephen Bagley
This map shows the geographic impact of Stephen Bagley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Bagley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Bagley more than expected).
Fields of papers citing papers by Stephen Bagley
This network shows the impact of papers produced by Stephen Bagley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Bagley. The network helps show where Stephen Bagley may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen Bagley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 106 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer Hit paper breakdown → | 2017 | 390 |
| 2 | 2018 | 221 | |
| 3 | 2021 | 119 | |
| 4 | 2021 | 109 | |
| 5 | 2019 | 103 | |
| 6 | 2019 | 85 | |
| 7 | 2018 | 75 | |
| 8 | 2020 | 68 | |
| 9 | 2018 | 64 | |
| 10 | 2021 | 54 | |
| 11 | 2023 | 47 | |
| 12 | 2024 | 47 | |
| 13 | 2021 | 45 | |
| 14 | 2019 | 38 | |
| 15 | 2007 | 37 | |
| 16 | 1989 | 31 | |
| 17 | 2016 | 26 | |
| 18 | 2024 | 24 | |
| 19 | 2020 | 24 | |
| 20 | 2022 | 22 |
About Stephen Bagley
Stephen Bagley is a scholar working on Genetics, Oncology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Cancer Research, having authored 106 papers that have together received 2.1k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (51 papers), Cancer Immunotherapy and Biomarkers (18 papers), Radiomics and Machine Learning in Medical Imaging (18 papers), Cancer Genomics and Diagnostics (16 papers), CAR-T cell therapy research (14 papers), Lung Cancer Treatments and Mutations (7 papers), Immunotherapy and Immune Responses (6 papers) and MRI in cancer diagnosis (5 papers). The work is most often cited by research in Genetics (581 citations), Oncology (891 citations), Cancer Research (267 citations), Immunology (349 citations) and Radiology, Nuclear Medicine and Imaging (234 citations). Stephen Bagley has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Donald M. O’Rourke, Arati Desai, Corey J. Langer, Gerald P. Linette, Carl H. June, Joshua Bauml, Steven Brem, Charu Aggarwal, Jeffrey C. Thompson and MacLean P. Nasrallah. Their work appears in journals such as Neuro-Oncology, Journal of Clinical Oncology, Neuro-Oncology Advances, Journal of Thoracic Oncology and Journal of Neuro-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.